These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9219606)

  • 21. Opposing effects of phorbol-12-myristate-13-acetate, an activator of protein kinase C, on the signaling of structurally related human dopamine D1 and D5 receptors.
    Jackson A; Sedaghat K; Minerds K; James C; Tiberi M
    J Neurochem; 2005 Dec; 95(5):1387-400. PubMed ID: 16313517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and binding properties of several new dopaminergic ligands.
    Tuce Z; Soskić V; Joksimović J
    Drug Des Discov; 1994 Jun; 11(4):251-8. PubMed ID: 7727678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.
    Perachon S; Schwartz JC; Sokoloff P
    Eur J Pharmacol; 1999 Feb; 366(2-3):293-300. PubMed ID: 10082211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J; Dougherty JJ; Nichols RA
    J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
    Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
    J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct vasodilating effects of the new dopaminergic agonist Z1046 in human arteries.
    Teisman AC; Buikema H; van Veldhuisen DJ; de Zeeuw D; van Gilst WH
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):581-5. PubMed ID: 10774789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
    Khroyan TV; Barrett-Larimore RL; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Aug; 294(2):680-7. PubMed ID: 10900248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
    Doll MK; Nichols DE; Kilts JD; Prioleau C; Lawler CP; Lewis MM; Mailman RB
    J Med Chem; 1999 Mar; 42(5):935-40. PubMed ID: 10072690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin).
    Adlersberg M; Hsiung SC; Glickstein SB; Liu KP; Tamir H; Schmauss C
    J Neurochem; 2004 Aug; 90(4):865-73. PubMed ID: 15287892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic regulation of ion transport in gills of the euryhaline semiterrestrial crab Chasmagnathus granulatus: interaction between D1- and D2-like receptors.
    Genovese G; Senek M; Ortiz N; Regueira M; Towle DW; Tresguerres M; Luquet CM
    J Exp Biol; 2006 Jul; 209(Pt 14):2785-93. PubMed ID: 16809469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dopamine receptor agonists on the cAMP content in arteries of the rabbit.
    Zhu L; Zhao RR; Zhang WF
    Sheng Li Xue Bao; 2000 Jun; 52(3):247-51. PubMed ID: 11956574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptors.
    Vendrell M; Soriano A; Casadó V; Díaz JL; Lavilla R; Canela EI; Lluís C; Franco R; Albericio F; Royo M
    ChemMedChem; 2009 Sep; 4(9):1514-22. PubMed ID: 19557804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS; Mabrouk OS; Pehek EA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular actions of the dopamine receptor agonist Z1046 in swine.
    Duncker DJ; van Meegen JR; Verdouw PD
    Cardiovasc Drugs Ther; 1997 Sep; 11(4):537-45. PubMed ID: 9358958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The collecting duct, dopamine and vasopressin-dependent hypertension.
    Schafer JA; Li L; Sun D
    Acta Physiol Scand; 2000 Jan; 168(1):239-44. PubMed ID: 10691807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D
    Yang L; Yao Y; Yong L; Feng Y; Su H; Yao Q; Xue J; Lu W; Zhou T
    Eur J Pharmacol; 2019 Sep; 859():172499. PubMed ID: 31242439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.